NCT02340130View on ClinicalTrials.gov

Safety, Tolerability and Efficacy of the Depigmented Modified Allergen Extract of Two Mites in Subjects With Allergic Rhinitis or Rhinoconjunctivitis, With Controlled Allergic Asthma

PHASE2CompletedINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

May 31, 2018

Study Completion Date

June 30, 2018

Conditions
RhinitisRhinoconjunctivitisAsthma
Interventions
BIOLOGICAL

DP/MG/14-1

The administration regimen will consist of a rush build-up régimen and a follow up period

BIOLOGICAL

DP/MG/14-2

The administration regimen will consist of a rush build-up régimen and a follow up period

Trial Locations (3)

15706

Hospital de Conxo, Santiago de Compostela

27003

Hospital Lucus-Augusti, Lugo

38010

Hosp Ntra Sra de la Candelaria, Santa Cruz de Tenerife

Sponsors
All Listed Sponsors
lead

Laboratorios Leti, S.L.

INDUSTRY

NCT02340130 - Safety, Tolerability and Efficacy of the Depigmented Modified Allergen Extract of Two Mites in Subjects With Allergic Rhinitis or Rhinoconjunctivitis, With Controlled Allergic Asthma | Biotech Hunter | Biotech Hunter